Expert insights. Personalized for you.
Germany has awarded a tender to a consortium led by IBM to develop a secure app that will provide a digital version of the country’s paper vaccine certificates. The €2.7 million ($3.2 MORE
Two of the biggest drugmakers in the HIV space are teaming up on a combination therapy that has the potential to be a game-changer for patients diagnosed with the dangerous virus for which there is no known cure MORE
91 Algernon Pharmaceuticals has requested a pre-Investigational New Drug meeting with regulators in the hopes of launching a clinical trial in stroke patients for n,n-dimethyltryptamine, a naturally derived psychedelic compound MORE
IN BRIEF: As a marketer, most of us, like a Jungian archetype, are true Communicators. Yet are those skills only reserved for big budgets, bold pitches, and grand innovations? Or do we, as individuals, have a special responsibility to the public at this moment in time? MORE
Nineteen biotechs have now gone public in the first quarter of 2021, raising a combined $3.6 billion and continuing a surge that began during the coronavirus pandemic MORE
169 Nearly $20 billion was invested in biotechs developing cell-, gene- and tissue-based treatments in 2020, according to a new report from industry group ARM MORE
Less snow in winter, especially below 2,000 metres and less in spring at all altitudes, in all regions Credit: Eurac Research The results, published in the renowned scientific journal The Cryosphere, have made it possible to reliably describe snow trends at up to 2000 metres above sea level. MORE
The exact shape of healthcare’s post-COVID ‘new normal’ is still being framed, but it is clear that some trends are already taking shape – and one of the key ones is digital transformation in pharma. MORE
The commission, along with agencies in Europe, Canada and the U.K., plans to take a broader view of the potential anti-competitive effects to drug company acquisitions MORE
France and Germany are two out of more than a dozen countries that suspended deployment of the AstraZeneca-Oxford University vaccine after reports of blood clots were reported MORE
Genetic Testing Marketplace Advances at Fastest Pace in History Despite COVID-19 Outbreak: Why More Physicians Now Use Genetic Tests and How Payers Want to Control Utilization, Prices Genetic Testing Marketplace Advances at Fastest Pace in History Despite COVID-19 Outbreak: Why … Continue reading → Business Wire MORE
Nearly half of parents have noticed a new or worsening mental health condition in their teen since the pandemic started; 3 in 4 say COVID-19 has negatively affected teens’ social interactions. Credit: C.S. MORE
DeepVerge has announced trial data showing its COVID-19 Microtox BT breath test can deliver accurate results in under 60 seconds, with a potential roll-out later this year if further tests support it. MORE
With more European countries pausing dosing of AstraZeneca’s COVID-19 vaccine over concerns about potential blood clotting side effects, Russia is seeking to fill in the gaps with its Sputnik V vaccine MORE
Persistent work from scientists at The University of Toledo could aid in diagnosing and treating postural orthostatic tachycardia syndrome Credit: Daniel Miller / The University of Toledo The symptoms of postural orthostatic tachycardia syndrome, or POTS, can be as varied as they are confounding. MORE
The rivals are now working together on oral and injectable treatments that combine their closely watched experimental drugs lenacapavir and islatravir MORE
Why the Apple Watch will likely be one of the top choices for use by sponsors, CROs and clinical trial teams wishing to use wearables in their trials MORE
An FDA request for more data, which comes on the heels of troubling results from a safety study of Pfizer's Xeljanz, could push back by three months AbbVie's plans to get Rinvoq approved in psoriatic arthritis MORE
Monitoring patient safety during a clinical trial is one of the founding principles to be followed throughout the drug development life cycle. It can be defined as a collaborative relationship between sponsors, sites, researchers, and everyone involved in the clinical trial phases. MORE
The FDA will limit the use of monoclonal antibody treatments developed by Regeneron and Eli Lilly due to concerns the medications are not effective against these new strains MORE
Credit: Sangheon Oh/Nature Nanotechnology Training neural networks to perform tasks, such as recognizing images or navigating self-driving cars, could one day require less computing power and hardware thanks to a new artificial neuron device developed by researchers at the University of California San Diego. MORE
Highly anticipated results from a Phase 2 study of donanemab showed treatment slowed disease progression, but mixed data on other measures could temper optimism in its potential MORE
Pennsylvania-based Ocugen has struck a deal to sell 100 million doses of a COVID-19 vaccine India’s Bharat Biotech in the United States later this year MORE
SUMMARY: Via the Financial Times , “pharmaceutical companies have never had it so good. MORE
The drugmaker defended its shot following reports of blood clots among vaccine recipients, noting more than 17 million people in the U.K. and Europe have now received it MORE
A treatment that sprays synthetic messenger RNA into the lungs failed to help cystic fibrosis patients, a blow to efforts to use the technology for more than vaccines MORE
Study results for donanemab showed signs of slowing disease progression, but the company believes the FDA won't review until another study confirms that apparent benefit MORE
Review included available safety data from over 17 million people vaccinated in the EU and UK with COVID-19 jab MORE
A host of companies are looking at cough apps to detect the presence of COVID-19. But one company called Hyfe wants to take the idea a step further and use them to detect future pandemics, reports Richard Staines. . MORE
SUMMARY: The FDA wants to look at how certain brand names affect consumer and health care providers’ perceptions about the efficacy and the medical conditions for which they’re indicated. This is just another example of how clueless the FDA is regarding patient behavior and prescription drugs. MORE
A study published in the journal Nature suggest the U.K. strain may cause a 61% higher risk of 28-day mortality MORE
103 
SUMMARY: Value-based healthcare is a healthcare delivery model in which providers, including hospitals and physicians, are paid based on patient health outcomes. MORE
Credit: Thomas Gorochowski In a recent study led by the University of Bristol, scientists have shown how to simultaneously harness multiple forms of regulation in living cells to strictly control gene expression and open new avenues for improved biotechnologies. MORE
Extremely high medical bills are a huge problem in the United States, particularly for the cancer community. That’s why we are proud to announce our partnership with Upsolve , a free bankruptcy tool. Most people don’t realize that normally, filing for bankruptcy actually costs money. MORE
65 Bio Pharma Dive
MARCH 15, 2021
Why the Apple Watch will likely be one of the top choices for use by sponsors, CROs and clinical trial teams wishing to use wearables in their trials
World of DTC Marketing
MARCH 17, 2021
SUMMARY: Via the Financial Times , “pharmaceutical companies have never had it so good.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Scienmag
MARCH 16, 2021
Persistent work from scientists at The University of Toledo could aid in diagnosing and treating postural orthostatic tachycardia syndrome Credit: Daniel Miller / The University of Toledo The symptoms of postural orthostatic tachycardia syndrome, or POTS, can be as varied as they are confounding.
Pharma Phorum
MARCH 17, 2021
Germany has awarded a tender to a consortium led by IBM to develop a secure app that will provide a digital version of the country’s paper vaccine certificates. The €2.7 million ($3.2
Bio Pharma Dive
MARCH 18, 2021
A treatment that sprays synthetic messenger RNA into the lungs failed to help cystic fibrosis patients, a blow to efforts to use the technology for more than vaccines
World of DTC Marketing
MARCH 18, 2021
SUMMARY: The FDA wants to look at how certain brand names affect consumer and health care providers’ perceptions about the efficacy and the medical conditions for which they’re indicated. This is just another example of how clueless the FDA is regarding patient behavior and prescription drugs.
Scienmag
MARCH 19, 2021
Clinical Research Informer brings together the best content for pharmaceutical professionals from the widest variety of industry thought leaders.
Bio Pharma Dive
MARCH 16, 2021
Nearly $20 billion was invested in biotechs developing cell-, gene- and tissue-based treatments in 2020, according to a new report from industry group ARM
World of DTC Marketing
MARCH 16, 2021
IN BRIEF: As a marketer, most of us, like a Jungian archetype, are true Communicators. Yet are those skills only reserved for big budgets, bold pitches, and grand innovations? Or do we, as individuals, have a special responsibility to the public at this moment in time?
Pharma Phorum
MARCH 19, 2021
DeepVerge has announced trial data showing its COVID-19 Microtox BT breath test can deliver accurate results in under 60 seconds, with a potential roll-out later this year if further tests support it.
BioSpace
MARCH 17, 2021
The FDA will limit the use of monoclonal antibody treatments developed by Regeneron and Eli Lilly due to concerns the medications are not effective against these new strains
Bio Pharma Dive
MARCH 16, 2021
The commission, along with agencies in Europe, Canada and the U.K., plans to take a broader view of the potential anti-competitive effects to drug company acquisitions
World of DTC Marketing
MARCH 19, 2021
SUMMARY: Value-based healthcare is a healthcare delivery model in which providers, including hospitals and physicians, are paid based on patient health outcomes.
Pharma Times
MARCH 15, 2021
Review included available safety data from over 17 million people vaccinated in the EU and UK with COVID-19 jab
BioSpace
MARCH 15, 2021
A study published in the journal Nature suggest the U.K. strain may cause a 61% higher risk of 28-day mortality
Bio Pharma Dive
MARCH 15, 2021
The rivals are now working together on oral and injectable treatments that combine their closely watched experimental drugs lenacapavir and islatravir
Scienmag
MARCH 19, 2021
Credit: Thomas Gorochowski In a recent study led by the University of Bristol, scientists have shown how to simultaneously harness multiple forms of regulation in living cells to strictly control gene expression and open new avenues for improved biotechnologies.
BioTech 365
MARCH 15, 2021
Genetic Testing Marketplace Advances at Fastest Pace in History Despite COVID-19 Outbreak: Why More Physicians Now Use Genetic Tests and How Payers Want to Control Utilization, Prices Genetic Testing Marketplace Advances at Fastest Pace in History Despite COVID-19 Outbreak: Why … Continue reading → Business Wire
BioSpace
MARCH 16, 2021
France and Germany are two out of more than a dozen countries that suspended deployment of the AstraZeneca-Oxford University vaccine after reports of blood clots were reported
Bio Pharma Dive
MARCH 15, 2021
Study results for donanemab showed signs of slowing disease progression, but the company believes the FDA won't review until another study confirms that apparent benefit
Scienmag
MARCH 18, 2021
Credit: Sangheon Oh/Nature Nanotechnology Training neural networks to perform tasks, such as recognizing images or navigating self-driving cars, could one day require less computing power and hardware thanks to a new artificial neuron device developed by researchers at the University of California San Diego.
Pharma Phorum
MARCH 19, 2021
A host of companies are looking at cough apps to detect the presence of COVID-19. But one company called Hyfe wants to take the idea a step further and use them to detect future pandemics, reports Richard Staines. .
Triage Cancer
MARCH 16, 2021
Extremely high medical bills are a huge problem in the United States, particularly for the cancer community. That’s why we are proud to announce our partnership with Upsolve , a free bankruptcy tool. Most people don’t realize that normally, filing for bankruptcy actually costs money.
Bio Pharma Dive
MARCH 15, 2021
The drugmaker defended its shot following reports of blood clots among vaccine recipients, noting more than 17 million people in the U.K. and Europe have now received it
Scienmag
MARCH 18, 2021
BioSpace
MARCH 16, 2021
Algernon Pharmaceuticals has requested a pre-Investigational New Drug meeting with regulators in the hopes of launching a clinical trial in stroke patients for n,n-dimethyltryptamine, a naturally derived psychedelic compound
NY Times
MARCH 13, 2021
Nursing homes have manipulated the influential star system in ways that have masked deep problems — and left them unprepared for Covid-19.
Bio Pharma Dive
MARCH 13, 2021
Highly anticipated results from a Phase 2 study of donanemab showed treatment slowed disease progression, but mixed data on other measures could temper optimism in its potential
Scienmag
MARCH 17, 2021
Less snow in winter, especially below 2,000 metres and less in spring at all altitudes, in all regions Credit: Eurac Research The results, published in the renowned scientific journal The Cryosphere, have made it possible to reliably describe snow trends at up to 2000 metres above sea level.
BioSpace
MARCH 14, 2021
With more European countries pausing dosing of AstraZeneca’s COVID-19 vaccine over concerns about potential blood clotting side effects, Russia is seeking to fill in the gaps with its Sputnik V vaccine
Cloudbyz
MARCH 17, 2021
Monitoring patient safety during a clinical trial is one of the founding principles to be followed throughout the drug development life cycle. It can be defined as a collaborative relationship between sponsors, sites, researchers, and everyone involved in the clinical trial phases.
Bio Pharma Dive
MARCH 18, 2021
An FDA request for more data, which comes on the heels of troubling results from a safety study of Pfizer's Xeljanz, could push back by three months AbbVie's plans to get Rinvoq approved in psoriatic arthritis
Scienmag
MARCH 14, 2021
Nearly half of parents have noticed a new or worsening mental health condition in their teen since the pandemic started; 3 in 4 say COVID-19 has negatively affected teens’ social interactions. Credit: C.S.
BioSpace
MARCH 14, 2021
Two of the biggest drugmakers in the HIV space are teaming up on a combination therapy that has the potential to be a game-changer for patients diagnosed with the dangerous virus for which there is no known cure
Pharma Phorum
MARCH 19, 2021
The exact shape of healthcare’s post-COVID ‘new normal’ is still being framed, but it is clear that some trends are already taking shape – and one of the key ones is digital transformation in pharma.
Bio Pharma Dive
MARCH 19, 2021
Nineteen biotechs have now gone public in the first quarter of 2021, raising a combined $3.6 billion and continuing a surge that began during the coronavirus pandemic
Scienmag
MARCH 19, 2021
Scientists from UNIGE and IRSET have established a link between poor semen quality in adult men and their mothers’ occupational exposure to endocrine disruptors during pregnancy.
Let's personalize your content